/Companies

Sexton Biotechnologies

Indianapolis, US · Founded 2019 · Delaware corporation · 2 known investors

Find your way into Sexton Biotechnologies

Sign up to see every warm intro you have to Sexton Biotechnologies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sexton Biotechnologies team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

DD
Doug DayhoffNamed on SEC filing
SWSean Werner
Sean WernerPresident2019–2021Chief Technology Officer at Biolifesolutions
BK
Brad KingNamed on SEC filing

Board

ECEli Casdin
Eli CasdinBoard directorChief Investment Officer and Founder at Casdin Capital
MR
Mike RiceBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 1 round · 2019

▶$5MraisedOct 2019 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Doug DayhoffDirector
  • Sean WernerExecutive Officer, Director
  • Eli CasdinDirector
  • Brad KingDirector
  • Mike RiceDirector
Offering amount
$5M
Amount sold
$5M
Minimum investment
$500K
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Sexton Biotechnologies's investors?
Sexton Biotechnologies's investors include BioCrossroads, Casdin Capital.
How much funding has Sexton Biotechnologies raised?
Sexton Biotechnologies has disclosed $5M raised across 1 round.
Where is Sexton Biotechnologies headquartered?
Sexton Biotechnologies is headquartered in Indianapolis, US.